Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-09-26
2006-09-26
Siew, Jeffrey (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007230, C435S007900, C435S007910, C435S007920, C530S387100
Reexamination Certificate
active
07112408
ABSTRACT:
The present invention is directed to a method for determining whether a woman has, or is likely to develop, ovarian cancer based upon assays of the alpha subunit of haptoglobin.
REFERENCES:
patent: 5604106 (1997-02-01), Liotta et al.
patent: 5695761 (1997-12-01), Denhardt et al.
patent: 5712104 (1998-01-01), Yamamoto
patent: 5801004 (1998-09-01), Hudson et al.
patent: 5866119 (1999-02-01), Bandman et al.
patent: 5928883 (1999-07-01), Gleich et al.
patent: 6414219 (2002-07-01), Denhardt et al.
patent: 6686444 (2004-02-01), Ashkar
patent: 2002/0039753 (2002-04-01), Chai et al.
patent: 2002/0052308 (2002-05-01), Rosen et al.
Kibel, AS et al, 2000, J urol, 164(1): 192-6.
Zhau, HE, 1994, J Cell Biochem, Suppl 19: 208-216.
Cheung S T et al, 2002, Cancer Research, 62(16): 4711-21.
Ren, C et al, 1998, Cancer Res, 58(6): 1285-90.
Gingrich, JR et al, 1996, Cancer res, 56(18): 4096-4102.
Ko, TM, Chinese J Microbiol. Immunol.:149-1 57 (1980).
Ali, et al., “Intercellular Cell Adhesion Molecule-1, Vascular Cell Adhesion Molecule-1, and Regulated on Activation Normal T Cell Expressed and Secreted Are Expressed by Human Breast Carcinoma Cells and Support Eosinophil and Activation,”Am. J. Path. 157:313-321 (2000).
Alper, “Turning Sweet on Cancer,”Science 301:159-160 (2003).
Barker, et al., “Eosinophil Cationis Protein cDNA, Comparison with Other Toxic Cationic Proteins and Ribonucleases,”J. Immunol. 143:952-955 (1989).
Beintema, et al., “Amino Acid Sequence of the Nonsecretory Ribonuclease of Human Urine,”Biochemistry 27:4530-4538 (1988).
Berteau, et al., “Prostasin mRNA to Detect Prostate Cells in Blood of Cancer Patients,”Clin. Chem. Lab. Med. 37:S119 (1999).
Blumenthal, et al., “Degranulating Eosinophils in Human Endometriosis,”Am. J. Path. 156:1581-1588 (2000).
Chen, et al., “Down-Regulation of Prostasin Serine Protease: A Potential Invasion Suppressor in Prostate Cancer,”Prostate 48:93-103 (2001).
Chen, et al., “Prostasin Serine Protease Inhibits Breast Cancer Invasiveness and Is Transcriptionally Regulated by Promoter DNA Methylation,”Int. J. Cancer 97:323-329 (2002).
Coolen, et al., “Elevation of Brain-Type Creatine Kinase in Serum from Patients with Carcinoma,”Cancer 44:1414-1418 (1979).
Denhardt, et al., “Osteopontin: A Protein with Diverse Functions,”FASEB J. 7:1475-1482 (1993).
DeRisi, et al., “Use of a cDNA Microarray to Analyse Gene Expression Patterns in Human Cancer,”Nature Genetics 14:457-460 (1996).
Dorta, et al., “Tumour-Associated Tissue Eosinophilia as a Prognostic Factor in Oral Squamous Cell Carcinomas,”Histopathology 41:152-157 (2002).
Fernández-Aceñero, et al., “Prognostic Influence of Tumor-Associated Eosinophilic Infiltrate in Colorectal Carcinoma,”Cancer 88:1544-1548 (2000).
Giachelli, et al., “Molecular and Cellular Biology of Osteopontin,”Trends Cardiovasc. Med. 5:88-95 (1995).
Hakomori, “Glycosylation Defining Cancer Malignancy: New Wine in an Old Bottle,”Proc. Natl. Acad. Sci. USA 99:10231-10233 (2002).
Hamann, et al., “Sequence of Human Eosinophil-Derived Neurotoxin cDNA: Identity of Deduced Amino Acid Sequence with Human Nonsecretory Ribonucleases,”Gene 83:161-167 (1989).
Hamann, et al., “Structure and Chromosome Localization of the Human Eosinophil-Derived Neurotoxin and Eosinophil Cationic Protein Genes: Evidence for Intronless Coding Sequences in the Ribonuclease Gene Superfamily,”Genomics 7:535-546 (1990).
Heid, et al., “Real Time Quantitative PCR,”Genome Res. 6:986-994 (1996).
Hooper, et al., “Testisin, a New Human Serine Proteinase Expressed by Premeiotic Testicular Germ Cells and Lost in Testicular Germ Cell Tumors,”Cancer Res. 59:3199-3205 (1999).
Hooper, et al., “Localization, Expression and Genomic Structure of the Gene Encoding the Human Serine Protease Testisin,”Biochimica et Biophysica Acta 1492:63-71 (2000).
Kakugawa, et al., “Up-Regulation of Plasma Membrane-Associated Ganglioside Sialidase (Neu3) in Human Colon Cancer and Its Involvement in Apoptosis Suppression,”Proc. Natl. Acad. Sci. USA 99:10718-10723 (2002).
Kiefer, et al., “The cDNA and Derived Amino Acid Sequence for Human Osteopontin,”Nuc. Ac. Res. 17:3306 (1989).
Kodama, et al., “Large Cell Carcinoma of the Lung Associated with Marked Eosinophilia,”Cancer 54:2313-2317 (1984).
Kurtz, et al., “Serum Creatine Kinase BB Isoenzyme as a Diagnostic Aid in Occult Small Cell Lung Cancer,”Cancer 56:562-566 (1985).
Mok, et al., “Molecular Cloning of Differentially Expressed Genes in Human Epithelial Ovarian Cancer,”Gynecologic Oncol. 52:247-252 (1994).
Mok, et al., “SPARC, an Extracellular Matrix Protein with Tumor-Suppressing Activity in Human Ovarian Epithelial Cells,”Oncogene 12:1895-1901 (1996).
Müeller-Pillasch, et al., “Cloning of a Gene Highly Overexpressed in Cancer Coding for a Novel KH-Domain Containing Protein,”Oncogene 14:2729-2733 (1997).
Oldberg, et al., “Cloning and Sequence Analysis of Rat Bone Sialoprotein (Osteopontin) cDNA Reveals an Arg-Gly-Asp Cell-Binding Sequence,”Proc. Natl. Acad. Sci. USA 83:8819-8823 (1986).
Oldberg, et al., “Identification of a Bone Sialoprotein Receptor in Osteosarcoma Cells,”J. Biol. Chem. 263:19433-19436 (1988).
Pastr{grave over (n)}ák, et al., “Local Eosinophilia in Stroma of Tumors Related to Prognosis,”Neoplasma 31:323-326 (1984).
Patarca, et al., “Differential Induction of Interferon γ Gene Expression after Activation of CD4+Cells by Conventional Antigen and Mls Superantigen,”Proc. Natl. Acad. Sci. USA 882736-2739 (1991).
Rosenberg, et al., “Molecular Cloning of the Human Eosinophil-Derived Neurotoxin: A Member of the Ribonuclease Gene Family,”Proc. Natl. Acad. Sci. USA 86:4460-4464 (1989).
Sakakibara, et al., “A Putative Mouse Oocyte Maturation Inhibitory Protein from Urine of Pregnant Women: N-Terminal Sequence Homology with Human Nonsecretory Ribonuclease,”Chem. Pharm. Bull. 39:146-149 (1991).
Sakakibara, et al., “Characterization of a Unique Nonsecretory Ribonuclease from Urine of Pregnant Women,”J. Biochem. 111:325-330 (1992).
Samoszuk, et al., “New Marker for Blood Vessels in Human Ovarian and Endometrial Cancers,”Clin. Cancer Res. 2:1867-1871 (1996).
Samoszuk, et al., “Occult Deposition of Eosinophil Peroxidase in a Subset of Human Breast Carcinomas,”Am. J. Pathol. 148:701-706 (1996).
Samoszuk, “Eosinohils and Human Cancer,”Histol. Histopathol. 12:807-812 (1997).
Schleich, et al., “Serum Ribonuclease Activity in Patients with Ovarian Tumors,”Eur. J. Gynaec. Oncol. 7:76-81 (1986).
Schleich, et al., “Ovarian Carcinoma: Increase in Clinical Validity by Simultaneous Determination o f SRA and CA 125,”J. Cancer Res. Clin. Oncol. 113:603-607 (1987).
Schneider, et al., “Osteopontin But Not Osteonectin Messenger RNA Expression Is a Prognostic Marker in Curatively Resected Non-Small Cell Lung Cancer,”Clin. Cancer Res. 10:1588-1596 (2004).
Schriml, et al., “Tyramide Signal Amplification (TSA)-FISH Applied to Mapping PCR-Labeled Probes Less Than 1 kb in Size,”BioTechniques 27:608-613 (1999).
Schummer, et al., “Comparative Hybridization of an Array of 21 500 Ovarian cDNAs for the Discovery of Genes Overexpressed in Ovarian Carcinomas,”Gene 238:375-385 (1999).
Schwartz, “The Hypereosinophilic Syndrome and the Biology of Cancer,”N. Engl. J. Med. 348:1199-1200 (2003).
Senger, et al., “Elevated Expression of Secreted Phosphoprotein 1 (Osteopontin, 2ar) as a Consequence of Neoplastic Transformation,”Anticancer Res. 9:1291-1300 (1989).
Sharp, et al., “Tumor Cells Are the Source of Osteopontin and Bone Sialoprotein Expressi
Berkowitz Ross S.
Cramer Daniel W.
Mok Samuel C.
Skates Steven
Ye Bin
Davis Minh-Tam
Fitch Even Tabin & Flannery
Siew Jeffrey
The Brigham and Women's Hospital, Inc.
LandOfFree
Detection of ovarian cancer based upon alpha-haptoglobin levels does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of ovarian cancer based upon alpha-haptoglobin levels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of ovarian cancer based upon alpha-haptoglobin levels will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3583923